Skip to main content

Fidelity — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

258
Companies
$33.3B
Total invested
$152.8M
Avg. check
47
Industries
Health Care 11Biotechnology 10Medical 7Therapeutics 7Medical Device 4Manufacturing 4+41 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 258
ESS
January 2026

ESS is an energy storage company that designs and produces iron flow batteries for commercial and utility-scale energy storage applications.

Electronics · Wilsonville$15.0M Post-IPO Equity
PrognomiQ
January 2026

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

Biopharma · San Mateo$11.9M Venture - Series Unknown
IperionX
January 2026

IperionX is a leading American titanium metal and critical materials company.

Manufacturing · Charlotte$4.6M Grant
Mirador Therapeutics
January 2026

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

Biotechnology · San Diego$250.0M Series B
Century Therapeutics
January 2026

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Biotechnology · Philadelphia$135.0M Post-IPO Equity
Monte Rosa Therapeutics
January 2026

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Biotechnology · Basel$300.0M Post-IPO Equity
Kalaris Therapeutics (formerly AlloVir)
December 2025

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Biotechnology · Houston$50.0M Post-IPO Equity
Tenaya Therapeutics
December 2025

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Biopharma · San Francisco$60.0M Post-IPO Equity
Amaero International
December 2025

Amaero International is an Australian based company that manufactures large-format complex components in metal.

3D Printing · Notting Hill$22.8M Post-IPO Debt
Fulcrum Therapeutics
December 2025

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Biotechnology · Cambridge$175.0M Post-IPO Equity
Vera Therapeutics
December 2025

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Biotechnology · South San Francisco$261.0M Post-IPO Equity
Nuvalent
November 2025

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Biotechnology · Cambridge$500.0M Post-IPO Secondary
Carbon
November 2025

Carbon is a company that provides high-tech, waste reducing 3D printing services.

3D Printing · Redwood City$60.0M Venture - Series Unknown
Saluda Medical
November 2025

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Health Care · Bloomington$30.0M Venture - Series Unknown
Redwood Materials
October 2025

Redwood Materials is a battery recycling startup that makes electric vehicles and sustainable materials for circular supply chains.

Advanced Materials · Carson City$350.0M Series E
Kardigan
October 2025

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

Biopharma · South San Francisco$254.0M Series B
Glide Identity
October 2025

Glide Identity provides SIM-based cryptographic authentication and verification systems using telecom network APIs.

Cyber Security · San Francisco$20.0M Series A
Skyryse
October 2025

Skyryse is a manufacturing firm that offers aerospace hardware and software operating systems and components design, production, and sales.

Aerospace · El Segundo$167.1M Series C
Empower Semiconductor
September 2025

Empower Semiconductor is a technology company enabling the design of high efficiency, integrated voltage regulators in SoCs.

Artificial Intelligence (AI) · Milpitas$140.0M Series D
Lightmatter
September 2025

Lightmatter develops photonic chips that enable data processing and communication using light instead of electricity.

AI Infrastructure · Mountain ViewSeries D
Moby
September 2025

Moby provides regular investors access to tactics that were previously only available to Wall Street's behemoths.

Finance · New York$5.0M Seed
Galvanize Therapeutics
September 2025

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Health Care · San Carlos$100.0M Series C
Treeline Biosciences
September 2025

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Biotechnology · Watertown$200.0M Series A
Conformal Medical
August 2025

Conformal Medical is an early stage medical device company developing devices to prevent stroke in patients.

Health Care · Nashua$31.8M Series D

Where Fidelity invests

Health Care11
Biotechnology10
Medical7
Therapeutics7
Medical Device4
Manufacturing4

About Fidelity's portfolio

How many companies has Fidelity invested in?▸

Fidelity has invested in 258 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?▸

Fidelity's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 47 different industry categories.

What is Fidelity's largest investment?▸

Among tracked funding rounds, Nuvalent received $500.0M in a Post-IPO Secondary round. Fidelity's total known invested capital is $33.3B.

What is the average investment size for Fidelity?▸

Fidelity's average investment size is $152.8M across its portfolio of 258 companies.

What are Fidelity's most recent investments?▸

Recent Fidelity portfolio additions include ESS, PrognomiQ, IperionX, Mirador Therapeutics, Century Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 258 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →